Piotr Ponikowski
Wroclaw Medical University, University Hospital, 4 Wojskowy Szpital Kliniczny z Poliklinika we Wroclawiu
Research areas: Medicine · Cardiology and Cardiovascular Medicine · Heart Failure Treatment and Management · Cardiovascular Function and Risk Factors · Heart rate and cardiovascular health
0000-0002-3391-7064
About
Piotr Ponikowski, MD PHD, FESC, FHFA is the professor of cardiology, Rector and the Head of Institute of Heart Diseases at Wroclaw Medical University, Poland.
His research interests focus on the pathophysiology and management of acute and chronic heart failure. He is co-author of more than 700 peer-reviewed papers with total number of citations: >120000, h-index=128; selected among Highly Cited Researchers by Thomson Reuters 2016, 2017, 2018, 2019, 2020.
In the years 2004-2019 professor Ponikowski served as a Member of Board of Heart Failure Association of the European Society of Cardiology (since 2004; in 2010-2012 as the President of Heart Failure Association), former President of Polish Cardiac Society (2015-2019).
He has been involved in the development of several guidelines on the management of cardiovascular diseases edited by the European Society of Cardiology (ESC) as the member of the ESC Committee for Practice Guidelines and was the Chair of the 2016 ESC Heart Failure Guidelines. He is a member of editorial boards for several cardiology-focused journals. Professor Ponikowski is an advisor and consultant for the range of pharmaceutical companies and has been a member of international steering/executive committees and endpoint committees of numerous clinical trials.
Employment
-
Wroclaw Medical University Head of Institute of Heart Diseases2021 - Present
-
University Hospital Head of Institute of Heart Diseases2021 - Present
-
Wrocław Medical University Rector2020 - Present
-
Wrocław Medical University Vice-rector for scientific affairs2016 - 2020
-
Wrocław Medical University Head of Deaprtment of Heart Diseases2009 - 2021
-
4 Wojskowy Szpital Kliniczny z Poliklinika we Wroclawiu Head of Cardiology Department2005 - 2019
-
4 Wojskowy Szpital Kliniczny z Poliklinika we Wroclawiu Consultant Cardiologist1997 - 2005
-
Royal Brompton Hospital Research Registrar1994 - 1996
- 1986 - 1993
Education
- 1980 - 1986
-
Uniwersytet Medyczny im Piastów Slaskich we Wroclawiu Professor of cardiology? - 2002
-
Uniwersytet Medyczny im Piastów Slaskich we Wroclawiu PhD thesis (PhD)? - 1997
-
Uniwersytet Medyczny im Piastów Slaskich we Wroclawiu doctorate thesis (MD)? - 1990
Projects & Funding
-
AMULET; A new model of medical care with use of modern methods of non-invasive clinical assessment and telemedicine in patients with heart failure National Centre for Research and Development2017 - 2020
-
LIPCAR as prognostic marker in heart failure with reduced ejection fraction National Centre for Research and Development2017 - 2020
-
A multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease European Commission2015 - 2020
-
Secondary prEvention of CardiovascUlaR disease in the Elderly trial European Commission2015 - 2020
-
Endovascular carotid body ablation in patients with treatment resistant hypertension: a safety and feasibility study Noblewell2014 - 2017
-
BIOSTAT-CHF: Ministry of Science and Higher Education2010 - 2015
-
Studies Investigating Co-morbidities Aggravating Heart Failure European Commission2009 - 2014
Publications (1206)
- Guideline-directed medical therapy and decongestion in patients with acute heart failure Save
- The polypill: the unmet need and great hope for heart failure patients Save
- Efficacy of Dapagliflozin According to Heart Rate: A Patient-Level Pooled Analysis of DAPA-HF and DELIVER Save
- Additional burden of iron deficiency in heart failure patients beyond the cardio-renal anaemia syndrome: findings from the BIOSTAT-CHF study Save
- Assessment of Proximal Tubular Function by Tubular Maximum Phosphate Reabsorption Capacity in Heart Failure Save
- Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology Save
- Biomarkers of Myocardial Injury and Remodeling in Heart Failure Save
- Cardiac contractility modulation therapy improves health status in patients with heart failure with preserved ejection fraction: a pilot study (CCM-HFpEF) Save
- Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure Save
- Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure Save
- Clinical implications of low estimated protein intake in patients with heart failure Save
- Clinical, laboratory associates and prognostic significance of hypocapnia in acute heart failure Save
- Contribution of Peripheral Chemoreceptors to Exercise Intolerance in Heart Failure Save
- Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA-HF Save
- Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials Save
- Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HF Save
- Developments in Exercise Capacity Assessment in Heart Failure Clinical Trials and the Rationale for the Design of METEORIC-HF Save
- Dilemmas on diagnosis and treatment of iron deficiency in patients after an episode of acute heart failure Save
- EMPAGLIFLOZIN IN PATIENTS HOSPITALIZED FOR DE NOVO VERSUS DECOMPENSATED CHRONIC HEART FAILURE: INSIGHTS FROM THE EMPULSE TRIAL Save
- EVENTS AVOIDED AND COST SAVINGS ASSOCIATED WITH FERRIC CARBOXYMALTOSE TREATMENT OF IRON DEFICIENCY IN PATIENTS WITH ACUTE HEART FAILURE WITH REDUCED EJECTION FRACTION FROM THE PERSPECTIVE OF HEALTHCARE PAYERS IN SWITZERLAND Save